Tillkännagivande • Apr 29
IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 19.999997 million. IDEX Biometrics ASA has filed a Follow-on Equity Offering in the amount of NOK 19.999997 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 2,424,242
Price\Range: NOK 8.25
Transaction Features: Rights Offering Tillkännagivande • Mar 06
IDEX Biometrics ASA announced that it expects to receive NOK 90.000001 million in funding IDEX Biometrics ASA announced a private placement to issue NOK 90,000,000 to ID centric in two tranches on March 5, 2026.The first tranche with 3,824,233 new shares at a price of NOK 5.83 per share for gross proceeds of NOK 2,2295,278.39 and it is getting closed on the same day. The second tranche with 11,613,159.795883 at a price of NOK 5.83 per share for gross proceeds of NOK 67,704,721.609998. The first tranche has been approved by the board of directors and an extraordinary general meeting will be held on or about March 27, 2026 to seek the necessary approval for the second tranche. Reported Earnings • Mar 05
Full year 2025 earnings released: US$0.26 loss per share (vs US$3.49 loss in FY 2024) Full year 2025 results: US$0.26 loss per share (improved from US$3.49 loss in FY 2024). Net loss: US$10.0m (loss narrowed 31% from FY 2024). Tillkännagivande • Jan 02
IDEX Biometrics ASA, Annual General Meeting, May 21, 2026 IDEX Biometrics ASA, Annual General Meeting, May 21, 2026. New Risk • Dec 23
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Norwegian stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Shareholders have been substantially diluted in the past year (over 5x increase in shares outstanding). Revenue is less than US$1m (US$209k revenue). Minor Risk Market cap is less than US$100m (kr362.3m market cap, or US$36.0m). Reported Earnings • Nov 15
Third quarter 2025 earnings released: US$0.02 loss per share (vs US$0.43 profit in 3Q 2024) Third quarter 2025 results: US$0.02 loss per share (down from US$0.43 profit in 3Q 2024). Net loss: US$992.0k (down 173% from profit in 3Q 2024). Tillkännagivande • Sep 27
Reserve Bank of India Approves Biometric Payment Authentication Technology Reserve Bank of India (RBI) has approved biometric authentication technology for digital payments, including IDEX's fingerprint payment solutions, through new authentication mechanisms for digital payment transactions directions effective April 2026. The RBI mandate specifically endorses fingerprint biometric authentication as an approved method for India's digital payment ecosystem, moving beyond traditional SMS-based one-time passwords. This regulatory approval validates IDEX's strategic positioning in the Indian market. The IDEX Pay solution performs biometric authentication directly on the payment card without requiring infrastructure changes to existing merchant terminals. The technology ensures biometric data remains encrypted and stored exclusively on the card, addressing the RBI's enhanced security requirements while maintaining user privacy. Tillkännagivande • Sep 12
IDEX Biometrics ASA Launches New Product Portfolio for Payment and Access Solutions IDEX Biometrics ASA announced the launch of its new product portfolio for payment and access solutions, accompanied by a redesigned website showcasing the company's advanced biometric authentication offerings. This launch marks a key milestone in the company's strategic transformation and delivery on previously communicated commitments. Reported Earnings • Aug 27
Second quarter 2025 earnings released: US$0.07 loss per share (vs US$2.29 loss in 2Q 2024) Second quarter 2025 results: US$0.07 loss per share (improved from US$2.29 loss in 2Q 2024). Net loss: US$2.07m (loss narrowed 69% from 2Q 2024). Tillkännagivande • Jul 22
IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 30 million. IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 30 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 4,731,594
Price\Range: NOK 3.3
Discount Per Security: NOK 0.165
Security Name: Shares
Security Type: Common Stock
Securities Offered: 4,359,315
Price\Range: NOK 3.3
Discount Per Security: NOK 0.165
Transaction Features: Subsequent Direct Listing Tillkännagivande • Jun 30
IDEX Biometrics ASA Announces Chief Financial Officer Changes, Effective 30 June 2025 IDEX Biometrics ASA announced that Kristian Flaten, Chief Financial Officer (CFO), has handed in his resignation as CFO to pursue other opportunities. The resignation is effective on 30 June 2025. Anders Storbråten, existing Chief Executive Officer, will also assume the role as Chief Financial Officer, as of the effective date of Kristian's resignation. Kristian will be available to support the Company in a transition period to secure a smooth handover of the CFO functions to Anders. Tillkännagivande • Jun 07
IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 6 million. IDEX Biometrics ASA has completed a Follow-on Equity Offering in the amount of NOK 6 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 600,000,000
Price\Range: NOK 0.01
Transaction Features: Rights Offering Tillkännagivande • May 21
IDEX Biometrics ASA Approves Board and Committee Changes IDEX Biometrics ASA initiated a restructuring of its organization in 2024 to align with business opportunities and reduce costs. The company is consolidating development and business operations primarily in the UK and the EU/EEA. During 2025, the restructuring continued with further cost reductions and changes to the commercial strategy, with new management in place. The Nomination Committee of IDEX Biometrics ASA proposes that Morten Opstad, Annika Olsson, and Adriana Saitta, all current board members and European residents and nationals, form the new board of directors, with Morten Opstad serving as the Chair. The proposal is that they continue for a new term of two years. The Nomination Committee proposes that Mr. Morten Opstad is elected for a new two-year term in the capacity as Chair, and Ms. Annika Olsson and Ms. Adriana Saitta are also elected for a new two-year term as board members. The Nomination Committee's chair, Mr. Robert N. Keith, and member Mr. Harald Voigt were elected for a 2-year term at the 2023 AGM and are now standing for election. Mr. Robert N. Keith is willing to continue to serve for a new two-year period. Mr. Harald Voigt is willing to continue to serve for a new one-year term. Member of the Nomination Committee, Mr. Håvard Nilsson, was elected for a two-year term at the annual general meeting in 2024. The Nomination Committee emphasizes that the composition of the Nomination Committee should be subject to review each year, regardless of the term of election. The Nomination Committee proposes that Mr. Håvard Nilsson will continue for the second year of his term at the Nomination Committee. Mr. Robert N. Keith, chair of the Nomination Committee, is elected as chair of the Nomination Committee for a new period of two years. Mr. Harald Voigt is elected as a member of the Nomination Committee for a one-year term. Tillkännagivande • May 08
IDEX Biometrics ASA to Report Q3, 2025 Results on Nov 13, 2025 IDEX Biometrics ASA announced that they will report Q3, 2025 results on Nov 13, 2025 Tillkännagivande • Oct 29
IDEX Biometrics ASA Announces Chief Financial Officer Changes IDEX Biometricshas appointed Kristian Flaten as Chief Financial Officer, effective November 1, 2024. Kristian Flaten brings over 25 years of financial leadership and experience with international business and financing, including from Asian growth markets, a strong focus for IDEX Biometrics. He has a proven track record in corporate finance, debt financing and business development in growth companies. Kristian has a background as CFO with Quantafuel ASA, recycling plastic waste, and as VP Corporate Finance with BW Offshore, oilfield services. Additionally, he has experience from the financial sector with Export Finance Norway and Handelsbanken. Kristian holds a Master of Science from NHH (Norwegian School of Economics), with majors in Finance and Strategy. He will be based at IDEX Biometrics headquarters in Oslo. Kristian Flaten is succeeding John Kurtzweil, who will continue to support the company in an advisory role. Tillkännagivande • Oct 23
IDEX Biometrics ASA to Report Q3, 2024 Results on Oct 29, 2024 IDEX Biometrics ASA announced that they will report Q3, 2024 results on Oct 29, 2024 Tillkännagivande • Aug 28
IDEX Biometrics ASA Introduces Biometric Payment Cards in India IDEX Biometrics is bringing biometric authentication onto payment cards for the Indian market, together with a worldwide leader in payment services. India boasts more than 1 billion payment cards in circulation and has been a frontrunner in biometrics for many years. Live user experience and technology testing for the IDEX Pay biometric payment cards has been conducted with Indian payment service partner, giving excellent results, and proving that biometric payment cards can be deployed in a seamless and secure manner throughout India. Newly published research indicates that more than 90% of affluent consumers in India want biometric payment cards. The Reserve Bank of India (RBI) is driving out secure digital payments and is in consultation with Indian banks to mandate alternative multi-factor authentication methods for digital payment transactions. This includes biometric authentication and specifically fingerprints. The payment landscape in India is set to change. With an opportunity to grow contactless payments from current low adoption levels of 16%, the biometric card represents a new secure and convenient payment solution for India. The biometric authentication is performed directly on the payment card, no change to existing payment terminals and infrastructure is needed. Equally important, the IDEX Pay technology ensures cardholder's biometric data never leaves the card, confirming highest level of security and privacy for the consumer. Tillkännagivande • Aug 22
IDEX Biometrics ASA Announces Chief Executive Officer Changes IDEX Biometrics ASA has appointed Catharina Eklof as the new Chief Executive Officer, effective as of 19 August 2024. Catharina Eklof has for the last three years served as Chief Commercial Officer for IDEX Biometrics, and has been instrumental in the transformation from a component provider to a full biometric solution company. Catharina brings global experience in business transformation and has been driving profitable growth initiatives and led commercialization of new technology solutions across industry leading global companies as Mastercard and Securitas. The company thank Vince Graziani for his contributions to the company through challenging times. Vince will continue to support the company in an advisory role. Tillkännagivande • May 18
IDEX Biometrics ASA Appoints Morten Opstad as Chair IDEX Biometrics ASA at its annual general meeting on 16 May 2024 elected Morten Opstad as Chair. Tillkännagivande • Nov 08
IDEX Biometrics ASA announced that it expects to receive NOK 100 million in funding IDEX Biometrics ASA announced that it has entered into a non-binding term sheet to issue senior convertible bond for the gross proceeds of NOK 100 million on November 7, 2023. The bonds will have a coupon rate of 6% per annum. The convertible bond will be issued at a price of 92% of the principal amount, and will be amortized over 3,5 years through instalment every 2 months over the period. The instalment periods may be altered during the amortizing period. Conversion price will be at a premium to the stock price at closing of the final agreements and any repayments by issuance of shares will be at a discount to market price at each instalment. The transaction subject to approval of the formal agreements and shareholder approval. Tillkännagivande • Sep 25
IDEX Biometrics ASA Announces Chief Financial Officer Changes IDEX Biometrics ASA has appointed John T. Kurtzweil as Chief Financial Officer effective September 25, 2023. Mr. Kurtzweil is a highly accomplished financial executive. He joins IDEX Biometrics after having served as CFO at Metabolon, where he was pivotal in revitalizing the company. Prior to Metabolon, he has served as CFO for CREE, Cirrus Logic and ON Semiconductor where he had key roles in finance operations at large, and leading strategic planning as well as mergers and acquisitions, growing shareholder value. Mr. Kurtzweil succeeds Eileen Wynne who has been Interim CFO in IDEX Biometrics since August 2022. Ms. Wynne will continue as a consultant during a transition period. Tillkännagivande • Sep 01
IDEX Biometrics Payment Card Solution Fully Certified by Mastercard IDEX Biometrics has successfully completed the full Mastercard certification and received Conformity Compliance Statement (CCS) for its IDEX Biometrics Payment Card solution. The complete and certified biometric card solution includes the IDEX biometric sensor, a Linxens EMV module including Infineon's SLC38B secure element, card inlay with antenna, and the IDEX card operating system with payment applets. Biometric payment cards built on the IDEX Biometrics payment card solution will provide seamless payment experiences for consumers around the world. The IDEX Biometrics payment Card solution has successfully completed Mastercard's Compliance Assessment and Security Testing (CAST). This is the final Mastercard certification step and follows the previously announced FTAS certification of the sensor performance. Smartcard manufacturers can now fully leverage this certification for their Letters of Approval (LoA) without having to complete compliance tests on their own, significantly reducing development cost and time to market. More than 15 global and regional card manufacturers and resellers have already selected the IDEX Biometrics certified payment card solution, as they respond to the increasing demand from banks and fintechs for biometric payment cards. Mastercard Compliance Assessment and Security Testing (Cast) and Interface and Application Testing (IAT). Testing performed by independent certified test labs accredited by EMVCo and qualified by Mastercard2 EMV stands for Europay, Mastercard and Visa. Tillkännagivande • Jul 23
IDEX Biometrics Announces Intention to Voluntary Delist of American Depositary Shares from the Nasdaq Capital Market IDEX Biometrics ASA announced it has given formal notice to the Nasdaq Stock Market of the Company’s intention to voluntary delist American Depositary Shares (“ADSs’) representing its ordinary shares, which is anticipated to be effective prior to the opening of trading on August 10, 2023. Each ADS represents 75 ordinary shares of the Company. Ordinary shares of IDEX Biometrics have been listed on the Oslo Bors since May 11, 2015, under the ticker IDEX.OL. The ordinary shares trade in Norwegian krone. The Company subsequently listed the ADSs on The Nasdaq Capital Market in March 2021 under the ticker IDBA. The ADSs trade in U.S. dollars. The ADS delisting will have no impact on the Company’s accounting standards, and IDEX intends to continue its disclosures in compliance with applicable Norwegian financial market regulations. IDEX intends to file a Form 25 and, thereafter, a Form 15F with the Securities and Exchange Commission (“SEC”) within the coming weeks to initiate the removal of the ADS listing and deregistration of the ADSs and underlying ordinary shares under the Securities Exchange Act of 1934, as amended (“Exchange Act”), and expects the ADS delisting to become effective on or around August 10, 2023, at which time the Company’s ADSs will no longer trade on The Nasdaq Capital Market and the IDEX reporting obligations with the SEC will be suspended. The Company expects that the deregistration of the ADSs and the underlying ordinary shares under the Exchange Act will become effective on or around October 29, 2023. Tillkännagivande • May 26
IDEX Biometrics ASA announced that it expects to receive NOK 150 million in funding IDEX Biometrics ASA announced a private placement to raise gross proceeds of NOK 150 million in an equity round of funding on May 24, 2023. The transaction will include participation from Norwegian and international investors. The private placement will be divided into two tranches. Tranche 1 will consist of 116,897,492 offer shares. Tranche 2 will consist of up to the number of offer shares that, together with the tranche 1 offer shares, is necessary to raise gross proceeds of NOK 150 million. The allocations of offer shares to investors are expected to be split between Tranche 1 and Tranche 2 on a pro rata basis. The investors are subject to applicable exemptions from relevant prospectus, filing or other registration requirements. The minimum application and allocation amount in the private placement will be the NOK equivalent of €100,000. The company will announce the final number of offer shares placed and the final offer price in a stock exchange announcement expected to be published before the opening of trading on the Oslo Stock Exchange tomorrow, 25 May 2023. The completion of Tranche 1 is subject to approval by the board. The completion of tranche 2 will be subject to approval by an extraordinary general meeting of the company expected to be held on or about 16 June 2023. The settlement of the Tranche 1 offer shares is expected to take place on a delivery versus payment basis on or about 30 May 2023. Settlement of the Tranche 2 offer shares is expected to take place on a delivery versus payment basis on or about 20 June 2023. Tillkännagivande • May 24
IDEX Biometrics ASA Approves the Election of Adriana Saitta as Board Member IDEX Biometrics ASA at its annual general meeting held on 23 May 2023 approved the election of Adriana Saitta as board member. Tillkännagivande • May 12
IDEX Biometrics Launches a Complete Biometric Payment Card Solution Leveraging Products and Technologies from STMicroelectronics IDEX Biometrics has developed an advanced solution for biometric smart cards, leveraging products and technologies from STMicroelectronics. The solution combines the biometric system from IDEX Biometrics with the latest Secure Element from ST and is fully integrated with ST's STPay-Topaz-Bio Operating System and payment applets. This high-performance solution includes the ST31N600 secure microcontroller with biometric features, packaged in a single-chip EMV module, and includes a cost- effective enrollment solution. Bringing these innovations to market enables cost efficiencies for manufacturers and significantly improves the user experience. The solution is now completely tested and validated, demonstrating market-leading biometric performance and transaction latency. This new IDEX Biometrics smart card solution is targeted for deployment with banks and issuers in the first half of 2024. Reported Earnings • May 02
Full year 2022 earnings: EPS and revenues exceed analyst expectations Full year 2022 results: US$0.032 loss per share. Revenue: US$4.09m (up 44% from FY 2021). Net loss: US$32.7m (flat on FY 2021). Revenue exceeded analyst estimates by 5.1%. Earnings per share (EPS) also surpassed analyst estimates by 3.7%. Revenue is forecast to grow 105% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Electronic industry in Norway. Reported Earnings • Feb 22
Full year 2022 earnings: EPS and revenues exceed analyst expectations Full year 2022 results: US$0.03 loss per share. Revenue: US$4.09m (up 44% from FY 2021). Net loss: US$32.7m (flat on FY 2021). Revenue exceeded analyst estimates by 5.1%. Earnings per share (EPS) also surpassed analyst estimates by 3.7%. Reported Earnings • Nov 16
Third quarter 2022 earnings released: US$0.009 loss per share (vs US$0.008 loss in 3Q 2021) Third quarter 2022 results: US$0.009 loss per share (further deteriorated from US$0.008 loss in 3Q 2021). Revenue: US$928.0k (up 27% from 3Q 2021). Net loss: US$9.02m (loss widened 21% from 3Q 2021). Revenue is forecast to grow 200% p.a. on average during the next 2 years, compared to a 34% growth forecast for the Electronic industry in Norway. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Reported Earnings • Nov 12
Third quarter 2022 earnings released: US$0.01 loss per share (vs US$0.008 loss in 3Q 2021) Third quarter 2022 results: US$0.01 loss per share (further deteriorated from US$0.008 loss in 3Q 2021). Revenue: US$928.0k (up 27% from 3Q 2021). Net loss: US$9.02m (loss widened 21% from 3Q 2021). Revenue is forecast to grow 193% p.a. on average during the next 2 years, compared to a 31% growth forecast for the Electronic industry in Norway. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Breakeven Date Change • Sep 28
Forecast to breakeven in 2024 The 2 analysts covering IDEX Biometrics expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 65% per year to 2023. The company is expected to make a profit of US$200.0k in 2024. Average annual earnings growth of 84% is required to achieve expected profit on schedule. Reported Earnings • Aug 12
Second quarter 2022 earnings released: US$0.01 loss per share (vs US$0.008 loss in 2Q 2021) Second quarter 2022 results: US$0.01 loss per share (down from US$0.008 loss in 2Q 2021). Revenue: US$1.11m (up 59% from 2Q 2021). Net loss: US$9.24m (loss widened 28% from 2Q 2021). Over the next year, revenue is forecast to grow 573%, compared to a 119% growth forecast for the industry in Norway. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. Reported Earnings • May 13
First quarter 2022 earnings: EPS and revenues miss analyst expectations First quarter 2022 results: US$0.01 loss per share (down from US$0.009 loss in 1Q 2021). Revenue: US$989.0k (up 59% from 1Q 2021). Net loss: US$8.12m (loss widened 7.9% from 1Q 2021). Revenue missed analyst estimates by 36%. Earnings per share (EPS) also missed analyst estimates by 38%. Over the next year, revenue is forecast to grow 474%, compared to a 169% growth forecast for the industry in Norway. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings. Reported Earnings • Feb 28
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: US$0.035 loss per share (vs US$0.035 loss in FY 2020). Net loss: US$32.6m (loss widened 22% from FY 2020). Revenue exceeded analyst estimates by 2.4%. Over the next year, revenue is forecast to grow 483%, compared to a 216% growth forecast for the industry in Norway. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings. Breakeven Date Change • Jan 01
Forecast to breakeven in 2024 The 2 analysts covering IDEX Biometrics expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of US$200.0k in 2024. Average annual earnings growth of 55% is required to achieve expected profit on schedule. Reported Earnings • Nov 06
Third quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 3Q 2020) The company reported a solid third quarter result with improved revenues and control over costs, although losses increased. Third quarter 2021 results: Revenue: US$732.0k (up 195% from 3Q 2020). Net loss: US$7.47m (loss widened 10.0% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 13
Second quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 2Q 2020) The company reported a solid second quarter result with improved revenues and control over costs, although losses increased. Second quarter 2021 results: Revenue: US$697.0k (up 368% from 2Q 2020). Net loss: US$7.24m (loss widened 13% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 23% per year, which means it is significantly lagging earnings. Reported Earnings • May 13
First quarter 2021 earnings released: US$0.01 loss per share (vs US$0.009 loss in 1Q 2020) First quarter 2021 results: Net loss: US$7.53m (loss widened 19% from 1Q 2020). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings. Executive Departure • May 04
Advisor has left the company On the 1st of May, Derek D'Antilio's tenure as Advisor ended after less than a year in the role. As of December 2020, Derek personally held 681.93k shares (kr2.0m worth at the time). Derek is the only executive to leave the company over the last 12 months. Reported Earnings • Apr 25
Full year 2020 earnings released: US$0.035 loss per share (vs US$0.054 loss in FY 2019) Full year 2020 results: Net loss: US$26.8m (loss narrowed 18% from FY 2019). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Recent Insider Transactions • Mar 03
Chief Executive Officer recently bought kr37m worth of stock On the 1st of March, Vincent Graziani bought around 150k shares on-market at roughly kr246 per share. This was the largest purchase by an insider in the last 3 months. Vincent has been a buyer over the last 12 months, purchasing a net total of kr38m worth in shares. Reported Earnings • Feb 26
Full year 2020 earnings released: US$0.03 loss per share (vs US$0.055 loss in FY 2019) Full year 2020 results: Net loss: US$26.8m (loss narrowed 18% from FY 2019). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings. Analyst Estimate Surprise Post Earnings • Feb 26
Revenue and earnings miss expectations Revenue missed analyst estimates by 3.8%. Earnings per share (EPS) also missed analyst estimates by 16%. Over the next year, revenue is forecast to grow 357%, compared to a 235% growth forecast for the Electronic industry in Norway. Is New 90 Day High Low • Feb 22
New 90-day high: kr3.33 The company is up 70% from its price of kr1.95 on 24 November 2020. The Norwegian market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 27% over the same period. Is New 90 Day High Low • Dec 28
New 90-day high: kr3.10 The company is up 49% from its price of kr2.08 on 29 September 2020. The Norwegian market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 7.0% over the same period. 